Colestyramine

4 trials 1 recruiting CCardiology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

3 Sponsors

23 Countries

Phase III

Phase II

Phase III: 3 Phase II: 1

Indications tested

Relapsing multiple sclerosis 2 Epidermolysis bullosa 1 Multiple sclerosis 1

Sponsors using this IMP

Novartis Pharma AG 2 Centre Hospitalier Universitaire De Nantes 1 Sanofi-Aventis Recherche & Developpement 1

All trials

4 total

Exploratory evaluation of the effect of cholestyramine on serum levels of persistent organic pollutants in obese patients Recruiting

2023-505116-37-00 Phase II 1 country Centre Hospitalier Universitaire De Nice
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis Ended

2024-514343-29-00 Phase III 16 countries Sanofi-Aventis Recherche & Developpement
Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis, followed by long term treat… Ended

2023-509345-12-00 Phase III 13 countries Novartis Pharma AG
Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis, followed by long term treat… Ended

2023-509372-41-00 Phase III 15 countries Novartis Pharma AG

Showing 1–4 of 4 trials

← All drugs A–Z